20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T39001 | FGFR-IN-1 | ||
FGFR-IN-1 is a highly effective inhibitor targeting the Fibroblast Growth Factor Receptor (FGFR) group, comprising FGFR1, FGFR2, and FGFR3, with an impressive inhibitory concentration (IC 50) of less than 100 nM (US20130... | |||
T37426 | FIIN-1 | FGFR irreversible inhibitor-1 | FGFR |
FIIN-1 (FGFR irreversible inhibitor-1) is an irreversible and selective FGFR inhibitor with Kd of 2.8, 6.9, 5.4, 120, 32 and 120 nM for FGFR1, FGFR2, FGFR3, FGFR4, Flt1, Flt14, respectively.FIIN-1 inhibited FGFR1, FGFR2,... | |||
T5044 | Futibatinib | TAS120,FGFR-IN-1 | FGFR |
Futibatinib (FGFR-IN-1) is a novel, potent and highly selective FGFR inhibitor, used for antitumor treatment. | |||
T76672 | Aprutumab | FGFR-moAb,FGFR2-TTC,BAY 1179470 | FGFR |
Aprutumab (BAY 1179470) is a human FGFR2 monoclonal antibody with affinity to FGFR2 isoforms FGFR2-IIIB and FGFR2-IIIC. Aprutumab is commonly used to synthesize antibody-drug conjugates. | |||
T62794 | FGFR-IN-5 | ||
FGFR-IN-5 is a potent inhibitor of FGFR. FGFR-IN-5 has potential for research in cancer diseases. | |||
T62522 | FGFR-IN-4 | ||
FGFR-IN-4 is a potent inhibitor of FGFR. FGFR-IN-4 has potential for cancer disease studies. | |||
T61528 | FGFR-IN-7 | ||
FGFR-IN-7 (compound 17) is an orally active, potent FGFR modulator with the ability to penetrate the blood-brain barrier. It exhibits neuroprotective properties, enhancing brain exposure and decreasing the likelihood of ... | |||
T79257 | FGFR-IN-11 | FGFR | |
FGFR-IN-11 (compound I-5) is an orally active, covalent inhibitor of FGFR, exhibiting IC50 values of 9.9 nM (FGFR1), 3.1 nM (FGFR2), 16 nM (FGFR3), and 1.8 nM (FGFR4). This compound demonstrates nanomolar potency in inhi... | |||
T62391 | FGFR-IN-6 | ||
FGFR-IN-6 (Compound 5) is an FGFR inhibitor. | |||
T64125 | FGFR-IN-8 | ||
FGFR-IN-8 is a potent, orally active FGFR inhibitor that inhibits both wild-type and mutant FGFR. FGFR-IN-8 acts on FGFR1 (IC50<0.5 nM), V564F-FGFR2 (IC5016: 189.1 nM), N549H-FGFR2 (IC50<0.5 nM), V555M-FGFR3 (IC50: 22.6 ... | |||
T61660 | FGFR-IN-3 | ||
FGFR-IN-3 (compound 6) is a highly potent and orally active modulator of FGFR (fibroblast growth factor receptor). It has the ability to penetrate the blood-brain barrier (BBB). Additionally, FGFR-IN-3 exhibits significa... | |||
T62653 | FGFR-IN-2 | ||
FGFR-IN-2 (compound 1) is a potent inhibitor of FGFR, acting on FGFR1 (IC50: 7.3 nM), FGFR2 (IC50: 4.3 nM), FGFR3 (IC50: 7.6 nM) and FGFR4 (IC50: 11 nM). | |||
T73316 | FGFR-IN-9 | ||
FGFR-IN-9 is a potent, reversible, and orally active inhibitor of the fibroblast growth factor receptor (FGFR) family, demonstrating IC50 values of 17.1 nM for FGFR4 WT, 29.6 nM for FGFR3, 30.7 nM for FGFR4 V550L, 46.7 n... | |||
TQ0256 | FGFR4-IN-1 | FGFR | |
FGFR4-IN-1 is a potent FGFR4 inhibitor (IC50: 0.7 nM). | |||
T11279 | FGFR1/DDR2 inhibitor 1 | Discoidin Domain Receptor (DDR) , FGFR , Others | |
FGFR1/DDR2 inhibitor 1 is an inhibitor of discoindin domain receptor 2 (DDR2) and fibroblast growth factor receptor 1 (FGFR1), with IC50 values of 31.1 nM, 108.4 nM and 3.2 nM for FGFR1, KG-1, and DDR2, respectively. | |||
T6082 | SSR128129E | SSR | FGFR |
SSR128129E (SSR) is an allosteric and orally-active FGFR1 inhibitor (IC50: 1.9 μM), but not affecting other related RTKs. | |||
T6836 | FIIN-2 | FGFR | |
FIIN-2, an irreversible, pan-FGFR inhibitor, inhibits FGFR1/2/3/4 with IC50 of 3.09 nM, 4.3 nM, 27 nM and 45.3 nM, respectively. | |||
T2347 | BLU9931 | FGFR | |
BLU9931 is the first selective small molecule inhibitor of FGFR4. | |||
T1948 | AZD4547 | VEGFR , FGFR | |
AZD4547, a new-type specific FGFR inhibitor, targets for FGFR1/2/3 (IC50: 0.2/2.5/1.8 nM in cell-free assays). | |||
T3492 | PD-166866 | PD166866 | FGFR , Autophagy |
PD-166866 is a selective FGFR tyrosine kinase inhibitor. |